Mehrzad Zarghouni, MD
Vascular & Interventional Radiology · Bellaire, TXNPI 1780900993
Payments from drug & device makers
What this record shows
This record is dominated by other: $114,082 of the $127,221 with a category attached, or 89.7%. Angiodynamics, Inc. accounts for 90.8% of it on its own, with 28 other manufacturers making up the rest. Among vascular & interventional radiology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 161 payments — averaging $790.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$116K
- Cardiovascular Systems Inc.$7K
- Endologix LLC$3K
- Bard Peripheral Vascular, Inc.$430
- Medtronic$258
- Philips North America LLC$180
- plus $1K from 23 others
What the payments were for
- Speaking & faculty fees$6,3005%
- Food & beverage$6,8405%
- Other$114,08290%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 69 | $115,529 |
| Cardiovascular Systems Inc. | 13 | $6,974 |
| Endologix LLC | 14 | $2,771 |
| Bard Peripheral Vascular, Inc. | 10 | $430 |
| Medtronic(2 entities) | 9 | $258 |
| Philips North America LLC | 3 | $180 |
| Ablative Solutions, Inc. | 1 | $108 |
| ETS Wound Care LLC | 3 | $88 |
| Tactile Systems Technology Inc | 5 | $87 |
| Stryker | 2 | $75 |
| Sirtex Medical Inc | 6 | $67 |
| Abbott | 2 | $56 |
| Globus Medical | 2 | $56 |
| Penumbra, Inc. | 1 | $54 |
| Mimedx Group, Inc. | 2 | $48 |
| Cook Medical LLC | 3 | $47 |
| Johnson & Johnson(2 entities) | 2 | $46 |
| Mindray DS USA, Inc. | 1 | $44 |
| Pfizer | 2 | $42 |
| Convatec Inc. | 1 | $40 |
| Boston Scientific | 2 | $38 |
| Inari Medical, Inc. | 1 | $38 |
| Smith+Nephew | 1 | $25 |
| Biotissue Holdings Inc. | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Reflow Medical Inc | 1 | $22 |
| Hartmann USA, Inc. | 1 | $22 |
| Coloplast | 1 | $14 |
| Cashflow Solutions, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$127,221 in reported general payments places this provider in the 95th percentile of 299 vascular & interventional radiology providers in Texas.
See all vascular & interventional radiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 202 | $171,284 |
| EliquisApixaban | 13 | $10,548 |
| Cilostazol | 24 | $448 |
| Pregabalin | 22 | $431 |
| Gabapentin | 16 | $384 |
| ClopidogrelClopidogrel Bisulfate | 40 | $341 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 36 | $239 |
| Atorvastatin Calcium | 16 | $167 |
| Tramadol Hcl | 36 | $143 |
| Ibuprofen | 30 | $134 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $79 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $46 | $171,284202 claims |
| PfizerEliquis | $42 | $10,54813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 299 vascular & interventional radiology providers in Texas.
Other vascular & interventional radiology in Bellaire
- William FoxBellaire$37K
- Eric HardeeBellaire$35K
- Orlando DiazHouston$611K
- Rahul ShethHouston$410K
- Miguel MonteroHouston$386K
- Joshua KubanHouston$301K
- Peiman HabibollahiHouston$254K
- Ahmed Abdel AalHouston$147K
- Varshana GurusamyHouston$141K
- Sanjeeva KalvaDallas$128K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.